Two recent reads got me thinking about this question: Genomic Foundationless Models: Pretraining Does Not Promise Performance, and the observation that deep-learning predictions of gene perturbation effects do not yet outperform simple linear methods.
Foundation models struggle with omic tasks such as gene perturbation prediction and genome representation because of a combination of intrinsic biological complexity and methodological limitations. Here is a structured breakdown of the key reasons.
Data challenges
- Sparsity and high dimensionality. Omic data (gene expression, epigenetics) often has thousands of features but limited samples, which leads to overfitting.
- Noise and variability. Technical artifacts such as batch effects, together with biological variability, reduce signal-to-noise ratios and complicate generalization.
- Privacy and accessibility. Sensitive genomic data restricts large-scale aggregation, limiting the diversity and volume of training data.
Biological complexity
- Non-linear interactions. Gene regulation involves intricate feedback loops, epistasis, and context-dependent interactions that are hard to model.
- Multi-modality and dynamics. Integrating diverse data types (DNA, RNA, proteins) and capturing temporal or spatial dynamics such as cell-state changes exceeds current model capabilities.
Architectural limitations
- Sequence length. Genomes are orders of magnitude longer than text sequences, which challenges Transformer-based models with limited context windows.
- Ignoring 3D structure. Models often overlook chromatin folding and epigenetic spatial interactions that are critical for gene regulation.
Learning paradigms
- Ineffective self-supervision. Tasks like masked nucleotide prediction may not capture higher-order biological functions such as gene ontology or pathway interactions.
- Task specificity. Broad pretraining can miss the nuances required for specialized tasks such as predicting CRISPR knockout effects.
Evaluation and interpretability
- Misaligned metrics. Performance metrics such as accuracy may not correlate with biological relevance or clinical utility.
- Black-box nature. Biologists require mechanistic insight, but foundation models often lack interpretability.
Practical barriers
- Validation costs. Experimental validation is slow and expensive, which hinders iterative model refinement.
- Regulatory hurdles. Compliance with data privacy laws such as GDPR complicates data sharing and reuse.
Emerging solutions
- Improved architectures. Hierarchical or sparse Transformers to handle long sequences, and graph neural networks for interaction networks.
- Better pretraining tasks. Incorporating gene ontology, pathway data, or synthetic data to enhance biological relevance.
- Multi-modal integration. Combining omics with imaging, clinical data, or literature to enrich context.
- Active learning. Prioritizing high-impact experiments to reduce validation costs.